Qingdao Baheal Medical Inc.
Shenzhen Stock ExchangeTotal Valuation
Qingdao Baheal Medical Inc. carries a market capitalization of 11.03B, placing it among publicly traded companies globally. Its enterprise value stands at 12.17B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 11.03B |
| Enterprise Value | 12.17B |
Share Statistics
Qingdao Baheal Medical Inc. currently has 525.62M shares outstanding.
| Shares Outstanding | 525.62M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Qingdao Baheal Medical Inc. trades at a trailing price-to-earnings ratio of 21.93. The price-to-sales ratio is 1.29, and the price-to-book ratio stands at 5.80.
| PE Ratio | 21.93 |
| PS Ratio | 1.29 |
| PB Ratio | 5.80 |
| P/TBV Ratio | 5.04 |
| P/FCF Ratio | 30.53 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Qingdao Baheal Medical Inc. trades at an EV/EBITDA multiple of 13.43 and an EV/FCF ratio of 28.55. The EV/Sales ratio of 1.48 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.43 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.48 |
| EV / EBITDA | 13.43 |
| EV / EBIT | 13.43 |
| EV / FCF | 28.55 |
Financial Position
Qingdao Baheal Medical Inc. maintains a current ratio of 1.51, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 132.51, indicating elevated leverage, while an interest coverage ratio of 9.54 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.51 |
| Quick Ratio | 0.60 |
| Debt / Equity | 132.51 |
| Debt / EBITDA | 3.57 |
| Interest Coverage | 9.54 |
Financial Efficiency
Qingdao Baheal Medical Inc. posts a return on equity of 25.72 and a return on invested capital of 13.94.
| Return on Equity (ROE) | 25.72 |
| Return on Assets (ROA) | 7.36 |
| Return on Invested Capital (ROIC) | 13.94 |
| Return on Capital Employed (ROCE) | 9.26 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 7.34 |
Taxes
Over the trailing twelve months, Qingdao Baheal Medical Inc. has paid 139.72M in income taxes, reflecting an effective tax rate of 18.58.
| Income Tax | 139.72M |
| Effective Tax Rate | 18.58 |
Stock Price Statistics
Qingdao Baheal Medical Inc.'s stock has gained approximately 1.64729% over the past 52 weeks. The 50-day moving average sits at 22.06, while the 200-day moving average is 23.67.
| Beta (5Y) | N/A |
| 52-Week Price Change | 1.64729% |
| 50-Day Moving Average | 22.06 |
| 200-Day Moving Average | 23.67 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Qingdao Baheal Medical Inc. generated 8.25B in revenue and converted that into 486.04M in net income, yielding earnings per share of 1.15. EBITDA reached 906.16M, while operating income came in at 906.16M.
| Revenue | 8.25B |
| Gross Profit | 3.11B |
| Operating Income | 906.16M |
| Pretax Income | 752.11M |
| Net Income | 486.04M |
| EBITDA | 906.16M |
| EBIT | 906.16M |
| Earnings Per Share (EPS) | 1.15 |
Balance Sheet
Qingdao Baheal Medical Inc. holds 1.99B in cash and equivalents against 3.24B in total debt, resulting in a net debt position of 1.19B. Total book value stands at 1.84B, with working capital of 1.69B providing operational flexibility.
| Cash & Cash Equivalents | 1.99B |
| Total Debt | 3.24B |
| Net Debt | 1.19B |
| Equity (Book Value) | 1.84B |
| Book Value Per Share | 3.46 |
| Working Capital | 1.69B |
Cash Flow
After subtracting -349.09M in capital expenditures, free cash flow totaled -349.09M - equivalent to -0.66 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -349.09M |
| Free Cash Flow | -349.09M |
| FCF Per Share | -0.66 |
Margins
Qingdao Baheal Medical Inc. operates with a gross margin of 37.68, reflecting its pricing power and cost economics. The operating margin of 10.98 and net profit margin of 5.89 provide insight into operational efficiency.
| Gross Margin | 37.68 |
| Operating Margin | 10.98 |
| Pretax Margin | 9.12 |
| Profit Margin | 5.89 |
| EBITDA Margin | 10.98 |
Dividends & Yields
The company's payout ratio of 63.20 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.88 |
| Dividend Yield | N/A |
| Payout Ratio | 63.20 |
| Shareholder Yield | -0.49 |
| FCF Yield | 3.28 |
Scores
Qingdao Baheal Medical Inc. posts an Altman Z-Score of 3.57, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.57 |